Literature DB >> 7834470

Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole.

R R Allison1, V Vongtama, J Vaughan, K H Shin.   

Abstract

Mucositis is a common and often serious acute morbidity when radiation is delivered to portals encompassing the oral cavity, pharynx, or esophagus. In an effort to minimize this side effect, the combination of sucralfate and fluconazole was prescribed to 40 patients. Half were given sucralfate, 1 g in suspension q.i.d. from the first week to the completion of radiation with fluconazole 100 mg., q.d. for 14 days initiated during the fourth week. The remaining individuals were placed on the same dosages of the two drugs dispensed simultaneously after symptoms appeared. For both cohorts the combination of sucralfate and fluconazole was effective in diminishing oral discomfort and pain associated with radiation and chemotherapy. When medication was delivered from the first week of therapy, all patients could achieve the prescribed radiation dose without treatment interruption and be maintained on a regular diet. The combination of drugs was also effective in minimizing symptoms once they appeared.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834470     DOI: 10.3109/07357909509024890

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

Review 3.  [The use of sucralfate in radiation oncology].

Authors:  C Belka; W Hoffmann; F Paulsen; M Barnberg
Journal:  Strahlenther Onkol       Date:  1997-05       Impact factor: 3.621

Review 4.  Interventions for treating oral mucositis for patients with cancer receiving treatment.

Authors:  Jan E Clarkson; Helen V Worthington; Susan Furness; Martin McCabe; Tasneem Khalid; Stefan Meyer
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

5.  The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

Authors:  Samuel Vokurka; Eva Bystrická; Vladimír Koza; Jana Scudlová; Vladislava Pavlicová; Dana Valentová; Jana Bocková; Lubica Misaniová
Journal:  Support Care Cancer       Date:  2005-03-30       Impact factor: 3.603

Review 6.  [The therapeutic management of radiogenic oral mucositis].

Authors:  W Dörr; I Dölling-Jochem; M Baumann; T Herrmann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 7.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Authors:  Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-06       Impact factor: 3.603

Review 8.  Radiation-Induced Oral Mucositis.

Authors:  Osama Muhammad Maria; Nicoletta Eliopoulos; Thierry Muanza
Journal:  Front Oncol       Date:  2017-05-22       Impact factor: 6.244

Review 9.  Treatment-induced mucositis: an old problem with new remedies.

Authors:  R P Symonds
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.